Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3). Although therapy-induced senescence (TIS) improves long-term outcomes, potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Eµ-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously. SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12- and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another approach is based on the high lysosomal activity of some senescent cells that renders them sensitive to lysosomal ATPase inhibitors94.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [94]
In the citing paper
“In preclinical models, proteotoxic stress not only drives entry into a senescent state, but also activates autophagy, which consequently buffers toxicity from misfolded SASP factors 44,45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“These findings suggest that mTOR inhibitors, commonly referred to as rapalogs, might induce or prevent senescence in a context- dependent manner 45,48,49 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Multiple factors involved in senescence induction, such as oxidative stress and proteotoxic stress, lead to protein misfolding, which in turn evokes endoplasmic reticulum stress via the unfolded protein response 45,53 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Reconversion of lactate to pyruvate by l-lactate dehydrogenase B fuels the TCA cycle out of the senescence-enforced enhancement of non-oxidative glucose metabolism (commonly referred to as the Warburg effect) 45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Gas chromatography mass spectrometry–based metabolite profiling in plants
Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., & Fernie, A. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.59 · Cited by 2,170
Self-citation
Cited by
Items 101–200 of 540
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
“These actions are needed to prevent an unfolded protein response with endoplasmic reticulum-associated protein degradation and, potentially, subsequent cell death (D¨orr et al., 2013).”
BackgroundInfluentialSelf-citationOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
“Recent studies utilizing cytostatic treatments have reported promising preliminary results, suggesting that therapy-induced senescence (TIS), a promising approach to induce cytostasis, may be effective in preventing tumor growth (Dorr et al., 2013; Baell et al., 2018).”
BackgroundCangi, M. G., Biavasco, R., Cavalli, G., Grassini, G., Dal-Cin, E., Campochiaro, C., Guglielmi, B., Berti, A., Lampasona, V., von Deimling, A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204924 · Cited by 112
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
De Conti, G., Dias, M. H., & Bernards, R. (2021) · Cancers · doi:10.3390/cancers13051118 · Cited by 111
“In a Eμ-Myc-driven mouse lymphoma model, persister cells tolerant to chemotherapy displayed a very active metabolism, with increased glucose consumption despite their senescent phenotype [34].”
BackgroundUnique features of the transcriptional response to model aneuploidy in human cells
Dürrbaum, M., Kuznetsova, A. Y., Passerini, V., Stingele, S., Stoehr, G., & Storchová, Z. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-139 · Cited by 110
“Inhibition of basal autophagy by bafilomycin A1 treatment causes proteotoxic stress [35].”
BackgroundFang, J., Yan, Y., Teng, X., Wen, X., Li, N., Peng, S., Liu, W., Donadeu, F. X., Zhao, S., & Hua, J. (2018) · Aging · doi:10.18632/aging.101602 · Cited by 109
“Studies have shown that UPR reactions occurs only in senescent cells with SASP [46].”
BackgroundTemporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk
Cassidy, L. D., Young, A. R. J., Young, C. N. J., Soilleux, E. J., Fielder, E., Weigand, B. M., Lagnado, A., Brais, R., Ktistakis, N. T., Wiggins, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14187-x · Cited by 108
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Fan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 128
“…GLS and PYCR1 gene loci, augmenting both mRNA and protein abundance of PYCR1 and GLS. Previous studies have demonstrated that many distinctive features of cellular senescence resemble those of activated fibroblasts ( 79 – 82 ), exerting several biological functions during cancer progression ( 83 ).”
BackgroundCellular Senescence and Ageing: Mechanisms and Interventions
Mylonas, A., & O’Loghlen, A. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.866718 · Cited by 106
“As mentioned, malfunctioning mitochondria and anomalies in oxidative phosphorylation (OXPHOS) are characteristic of senescence (Dorr et al., 2013).”
BackgroundSelective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubackova, S., Davidova, E., Rohlenova, K., Stursa, J., Werner, L., Andera, L., Dong, L., Terp, M. G., Hodny, Z., Ditzel, H. J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 101
“apoptotic proteins or downregulation of caspase-3 [42, 43], these cells undergo considerable changes in their metabolism, since senescence is an energetically demanding process requiring a steady supply of ATP [18, 44].”
BackgroundKavanagh, E. L., Lindsay, S., Halasz, M., Gubbins, L. C., Weiner-Gorzel, K., Guang, M. H. Z., McGoldrick, A., Collins, E., Henry, M., Blanco-Fernández, A., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.82 · Cited by 98
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
Höllein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F. X., Rudelius, M., Laitinen, I., Nilsson, L. M., Goga, A., Peschel, C., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584524 · Cited by 102
“Using synthetic lethal approaches, one can specifically target cells with certain genotypes/phenotypes to enhance the tumor therapeutic index.(17,45) To address whether the effects of SUMO inhibition wereMyc specific, P493-6 B lymphoma cells cultured with (Myc-off) or without (Myc-on) Tet were treated with AA and 2-D0…”
MethodSelf-citationCellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Olive Oil and the Hallmarks of Aging
Fernández del Río, L., Gutiérrez-Casado, E., Varela-López, A., & Villalba, J. (2016) · Molecules · doi:10.3390/molecules21020163 · Cited by 95
“The activation of the UPR seems to occur in all types of senescence, whatever the inducer is successive replications [105,106], oncogene activation [107], DNA-damaging agents [107,108], or oxidative stress [105].”
BackgroundDaurio, N. A., Tuttle, S. W., Worth, A. J., Song, E. Y., Davis, J. M., Snyder, N. W., Blair, I. A., & Koumenis, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2197 · Cited by 96
“In terms of metabolic targeting, it has been postulated that concurrently targeting adaptive responses to metabolic reprogramming can lead to significant enhancement of the therapeutic window for multiple chemotherapeutic modalities (33,34).”
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
“The selective elimination of senescent cells extends the survival of mice bearing TIS tumors, but not of those mice with a tumor resistant to senescence [223].”
BackgroundSenescent tumor cells: an overlooked adversary in the battle against cancer
Park, S. S., Choi, Y. W., Kim, J., Kim, H. S., & Park, T. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00717-5 · Cited by 113
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Self-citationThe role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
Karabicici, M., Alptekin, S., Karagonlar, Z. F., & Erdal, E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12916 · Cited by 104
The role of hydrogen sulfide in aging and age-related pathologies
Perridon, B. W., Leuvenink, H. G. D., Hillebrands, J., van Goor, H., & Bos, E. M. (2016) · Aging · doi:10.18632/aging.101026 · Cited by 96
“Other studies underscored the close relationship between metabolic changes and senescence [235, 241-243].”
BackgroundNon-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
Cayo, A., Segovia, R., Venturini, W., Moore-Carrasco, R., Valenzuela, C., & Brown, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158149 · Cited by 93
Shimizu, T., Sugihara, E., Yamaguchi‐Iwai, S., Tamaki, S., Koyama, Y., Kamel, W., Ueki, A., Ishikawa, T., Chiyoda, T., Osuka, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0914 · Cited by 98
“In addition, inhibition of metabolic processes or autophagy flux in quiescent fibroblasts or therapy-induced senescent lymphoma cells resulted in cell death (43, 44).”
BackgroundWebster, M. R., Xu, M., Kinzler, K. A., Kaur, A., Appleton, J., O'Connell, M. P., Marchbank, K., Valiga, A., Dang, V. M., Perego, M., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12330 · Cited by 88
“Schmitt et al. suggest that we can harness the senescent phenotype and its associated enzymes to target and kill slow-growing tumor cells (Dorr et al., 2013).”
BackgroundER Stress Response in Human Cellular Models of Senescence
Matos, L., Gouveia, A. M., & Almeida, H. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu129 · Cited by 89
“The occurrence of ER stress was reported in human senescence induced by tumor-associated mutations (38) or chemotherapeutic agents in neoplastic cells (39), but never in nonmodified senescent cells in vitro.”
BackgroundNon-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
“For example, mitochondrial integrity is essential for the regulation of certain features of the senescent phenotype including its secretory phase, and targeting the mitochondria and proteostatic pathways has been proposed as a potential antiSASP treatment (144).”
BackgroundCellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
“Senescent cells that are depleted of mitochondria have been shown to exhibit an elevated glycolysis activity and higher ATP levels on the contrary to other evidence [86].”
BackgroundResultInfluentialRecent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Sun, X., Zhao, P., Lin, J., Chen, K., & Shen, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.16 · Cited by 96
“Superoxide produced by mitochondrial aerobic respiration can cause oxidative stress in tumor cells([57-59]).”
BackgroundLi, F., Liu, P., Mi, W., Li, L., Anderson, N. M., Lesner, N. P., Burrows, M., Plesset, J. B., Majer, A. D., Wang, G., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00671-3 · Cited by 100
“GSK3 is a senolytic target in FIS liver cancer cells TIS cancer cells can be eliminated by senolytics that specifically induce their cell death: the combination of pro-senescence therapeutics and senolytics has emerged as a promising cancer treatment option 13,30,38–41 .”
Is Reliance on Mitochondrial Respiration a “Chink in the Armor” of Therapy-Resistant Cancer?
Wolf, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.001 · Cited by 85
Takebayashi, S., Tanaka, H., Hino, S., Nakatsu, Y., Igata, T., Sakamoto, A., Narita, M., & Nakao, M. (2015) · Aging Cell · doi:10.1111/acel.12351 · Cited by 84
“Recent studies have shown that cells undergoing OIS have higher OXPHOS activities compared with growing cells (Quijano et al., 2012; Dorr et al., 2013; Kaplon et al., 2013).”
BackgroundResultInfluentialUsing droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastoma
Lodrini, M., Sprüssel, A., Astrahantseff, K., Tiburtius, D., Konschak, R., Lode, H. N., Fischer, M., Keilholz, U., Eggert, A., & Deubzer, H. E. (2017) · Oncotarget · doi:10.18632/oncotarget.19076 · Cited by 90
“Emerging data indicate that implementing molecular characterization of tumor surrogates such as cell-free nucleic acids [23–29], exosomes [30], metabolites [31], circulating and disseminated tumor cells [32, 33] isolated from blood, bone marrow und urine will improve molecular disease assessment for treatment selectio…”
BackgroundPotassium channel activity controls breast cancer metastasis by affecting β-catenin signaling
Breuer, E.-K. Y., Fukushiro-Lopes, D. F., Dalheim, A. V., Burnette, M. D., Zartman, J. J., Kaja, S., Wells, C. M., Campo, L., Curtis, K. J., Romero-Moreno, R., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1429-0 · Cited by 92
Targeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Strohecker, A. M., & White, E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0196 · Cited by 84
Wagner, J., Damaschke, N., Yang, B., Truong, M., Guenther, C., McCormick, J., Huang, W., & Jarrard, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124366 · Cited by 83
“Recent studies have suggested senescent cells may provide a susceptible population in combination with drugs that alter metabolism in a synthetic lethal approach [31].”
BackgroundCellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 83
“excess in obesity may also drive and maintain senescence by disrupting other metabolic processes, including glucose utilization [25] and nucleotide production [26].”
BackgroundCellular senescence links mitochondria-ER contacts and aging
Ziegler, D. V., Martin, N., & Bernard, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02840-5 · Cited by 100
Impairing the radioresistance of cancer cells by hydrogenated nanodiamonds
Grall, R., Girard, H. A., Saad, L., Petit, T., Gesset, C., Combis-Schlumberger, M., Paget, V., Delić, J., Arnault, J., & Chevillard, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.034 · Cited by 87
Sahin, G. S., Lee, H., & Engin, F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101365 · Cited by 77
“ATF4 also activates the NLRP1 inflammasome directly in the presence of ER stress [38,39].”
BackgroundInfluentialPerez de Souza, L., Naake, T., Tohge, T., & Fernie, A. R. (2017) · GigaScience · doi:10.1093/gigascience/gix037 · Cited by 81
“approach was rapidly adopted in these communities also [2, 4-6].”
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“…by autophagywas counterintuitive, considering the role of autophagy in cellular quality and fitness checks, although it is possible that increased autophagy activity serves as a prosurvival factor in senescent cells, which are known to be resistant to the cell death machinery (Dörr et al. 2013).”
BackgroundInfluentialThe YAP-TEAD complex promotes senescent cell survival by lowering endoplasmic reticulum stress
Anerillas, C., Mazan-Mamczarz, K., Herman, A. B., Munk, R., Lam, K.-W. G., Calvo-Rubio, M., Garrido, A., Tsitsipatis, D., Martindale, J. L., Altés, G., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00480-4 · Cited by 76
Malavolta, M., Bracci, M., Santarelli, L., Sayeed, M. A., Pierpaoli, E., Giacconi, R., Costarelli, L., Piacenza, F., Basso, A., Cardelli, M., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/4159013 · Cited by 81
“(a) The reprogrammed metabolic pathway in cancer (Warburg effect or aerobic glycolysis) and some therapy-induced senescent cells, consisting in the switch of normal metabolism to support proliferation of cancer cells or production of SASP in senescent cells targeting glycolytic and other metabolic pathways, makes some…”
Defining Blood Plasma and Serum Metabolome by GC-MS
Kiseleva, O. I., Kurbatov, I. Y., Ilgisonis, E. V., & Poverennaya, E. V. (2021) · Metabolites · doi:10.3390/metabo12010015 · Cited by 101
Hou, X., Liu, Y., Liu, H., Chen, X., Liu, M., Che, H., Guo, F., Wang, C., Zhang, D., Wu, J., et al. (2015) · Scientific Reports · doi:10.1038/srep09065 · Cited by 85
Targeting metabolism in cellular senescence, a role for intervention
Nacarelli, T., & Sell, C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.049 · Cited by 85
“…during senescence in response to several senescence triggers including; oncogene-induced senescence (Moiseeva et al., 2009), genotoxic stress-induced senescence (Dorr et al., 2013,Liao et al., 2014,Wang et al., 2016), and replicative senescence (James et al., 2015,Takebayashi et al., 2015).”
BackgroundBrägelmann, J., Lorenz, C., Borchmann, S., Nishii, K., Wegner, J., Meder, L., Ostendorp, J., Ast, D., Heimsoeth, A., Nakasuka, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25728-8 · Cited by 85
Self-citationGiroud, J., Bouriez, I., Paulus, H., Pourtier, A., Debacq-Chainiaux, F., & Pluquet, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310788 · Cited by 73
Malavolta, M., Giacconi, R., Brunetti, D., Provinciali, M., & Maggi, F. (2020) · Cells · doi:10.3390/cells9040909 · Cited by 72
Grimm, M. R., Cetindis, M., Lehmann, M., Biegner, T., Munz, A., Teriete, P., Kraut, W., & Reinert, S. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-208 · Cited by 80
“Therefore, targeting IGF-1R pathway, reversal of hyperinsulinemia and IGF by dietry recommendations [16,34,199,204-217,248] or metformin [232] may decrease resistance of EGFR-TKI as well as reduce the risk of cancer recurrence in tumor patients [34].”
BackgroundLKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism
Zeng, Q., Chen, J., Li, Y., Werle, K. D., Zhao, R.-X., Quan, C.-S., Wang, Y.-S., Zhai, Y.-X., Jw, W., Youssef, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.290 · Cited by 74
Targeting tumor cell senescence and polyploidy as potential therapeutic strategies
Saleh, T., Carpenter, V. J., Bloukh, S., & Gewirtz, D. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.010 · Cited by 74
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Malavolta, M., Pierpaoli, E., Giacconi, R., Costarelli, L., Piacenza, F., Basso, A., Cardelli, M., & Provinciali, M. (2016) · Current Drug Targets · doi:10.2174/1389450116666150907105104 · Cited by 68
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
“When glucose utilization was blocked in a murine lymphoma model, chemotherapy-induced senescent tumor cells and their SASP were eliminated, resulting in the inhibition of inflammation and proliferation [204].”
BackgroundSelf-citationLiu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“2-deoxy-D-glucose (2DG) induces apoptosis more effectively in cyclophosphamide-induced senescent lymphoma cells than in non-SnCs, highlighting a potential senescence-specific vulnerability to glycolysis inhibitors [166].”
BackgroundEmerging roles of lnc RNA s in senescence
Montes, M., & Lund, A. H. (2016) · FEBS Journal · doi:10.1111/febs.13679 · Cited by 69
The role of mitochondria in cellular senescence
Ghosh‐Choudhary, S. K., Liu, J., & Finkel, T. (2021) · The FASEB Journal · doi:10.1096/fj.202101462r · Cited by 70
Khalil, R., Diab‐Assaf, M., & Lemaître, J.-M. (2023) · Cells · doi:10.3390/cells12060915 · Cited by 74
“In addition, Ras activation leads to senescence of human primary thyrocytes, which arise from the p16 pathway activation via an interaction between IL-8 and the C-X-C motif chemokine receptor 2 (CXCR2), also known as interleukin-8 receptor beta (IL-8RB) [64].”
BackgroundMiR-34a modulates ionizing radiation-induced senescence in lung cancer cells
He, X., Yang, A., McDonald, D. G., Riemer, E. C., Vanek, K. N., Schulte, B. A., & Wang, G. Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19267 · Cited by 64
“Cellular senescence is a state of permanent cell cycle arrest that can be triggered by continuous passage of cells in culture, oxidative stress, treatment with chemotherapeutic agents or radiation and activation of oncogenes such as Ras [5–11 , 27– 29].”
Cormenier, J., Martin, N., Deslé, J., Salazar-Cardozo, C., Pourtier, A., Abbadie, C., & Pluquet, O. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.003 · Cited by 64
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C.-W., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 64
“, 2013) are characteristics of cellular senescence, a stable cell cycle arrest (Aird and Zhang, 2014, 2015; Dörr et al., 2013; Hernandez-Segura et al., 2018; Wiley and Campisi, 2016).”
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis
Wang, L., Jin, H., Jochems, F., Wang, S., Lieftink, C., Martinez, I. M., Conti, G. D., Edwards, F., de Oliveira, R. L., Schepers, A. G., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00462-2 · Cited by 78
Was, H., Barszcz, K., Czarnecka, J., Kowalczyk, A., Bernas, T., Uzarowska, E., Koza, P., Klejman, A., Piwocka, K., Kaminska, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14066 · Cited by 61
“Interestingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blockade of glucose utilization or autophagy, which led to their selective elimination through caspase-12- and caspase-3mediated endoplasmic-reticulum-related apoptosis [63].”
BackgroundAn in-silico approach to predict and exploit synthetic lethality in cancer metabolism
Apaolaza, I., José‐Eneriz, E. S., Tobalina, L., Miranda, E., Gárate, L., Agirre, X., Prósper, F., & Planes, F. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00555-y · Cited by 68
“The increasing evidence of metabolic reprogramming of cancer cells makes it ideal to exploit the concept of synthetic lethality, as illustrated in different previous works 3, 4 .”
BackgroundSenescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 70
Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53
Kirschner, K., Samarajiwa, S. A., Cairns, J. M., Menon, S., Pérez-Mancera, P. A., Tomimatsu, K., Bermejo-Rodriguez, C., Ito, Y., Chandra, T., Narita, M., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005053 · Cited by 61
“Consistently, recent metabolomics studies showed that senescence can be associated with reduced lipid synthesis and increased fatty acid oxidation [49,50].”
BackgroundAutophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence
Lenain, C., Gusyatiner, O., Douma, S., van den Broek, B., & Peeper, D. S. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv124 · Cited by 61
Cellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
“Also, it is proposed that the high production of secreted cytokines in the SASP overcomes the cellular capacity for accurate protein synthesis and thus produces improper proteins and proteotoxic stress.(51) Interestingly, we found that the main housekeeping system to maintain protein homeostasis, the heat-shock protei…”
BackgroundTanaka, H., Takebayashi, S., Sakamoto, A., Igata, T., Nakatsu, Y., Saitoh, N., Hino, S., & Nakao, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.021 · Cited by 62
The p38‐activated ER stress‐ATF6α axis mediates cellular senescence
Kim, H. S., Kim, Y.-J., Lim, M. J., Park, Y.-G., Park, S. I., & Sohn, J. (2018) · The FASEB Journal · doi:10.1096/fj.201800836r · Cited by 68
“Ectopic expression of the cleaved ATF6a [ATF6 (1-373)], but not that of a DNA-binding mutant of the ATF6a (1-373) [ATF6 (1-373)m1], induced cellular senescence (Fig.”
BackgroundMethodUnfolded Protein Response (UPR) Controls Major Senescence Hallmarks
Abbadie, C., & Pluquet, O. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.02.005 · Cited by 61
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
“In particular, an increase in mitochondrial oxygen consumption and oxidative phosphorylation have been reported in oncogene-induced senescence in human fibroblasts [166, 167], oxidative stress-induced senescence [50, 168], therapy-induced senescence in lymphoma [169], and DNA damage-induced senescence [50].”
BackgroundA hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
Malaquin, N., Vancayseele, A., Gilbert, S., Antenor-Habazac, L., Olivier, M.-A., Ait Ali Brahem, Z., Saad, F., Delouya, G., & Rodier, F. (2020) · Cells · doi:10.3390/cells9071593 · Cited by 59
“Despite these mutations, cancer cells can often retain the capacity to enter senescence in response to treatments [16,20,29,30].”
BackgroundAdaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
Reimann, M., Schrezenmeier, J., Richter-Pechanska, P., Dolnik, A., Hick, T. P., Schleich, K., Cai, X., Fan, D. N. Y., Lohneis, P., Maßwig, S., et al. (2021) · Blood · doi:10.1182/blood.2020005244 · Cited by 59
Self-citationOxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells
Stabenow, L. K., Zibrova, D., Ender, C., Helbing, D. L., Spengler, K., Marx, C., Wang, Z.-Q., & Heller, R. (2022) · Cells · doi:10.3390/cells11142213 · Cited by 56
“The glycolytic state has often been linked to an increased need for macromolecule building blocks required for senescence-associated events, such as senescence-associated secretory phenotype (SASP), cell enlargement or increased oxidative and endoplasmic reticulum stress, and has been thought to compensate for reduced…”
BackgroundThe Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
Muralidharan, S. V., Bhadury, J., Nilsson, L. M., Green, L. C., McLure, K. G., & Nilsson, J. A. (2016) · Oncogene · doi:10.1038/onc.2015.521 · Cited by 64
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 64
Nacarelli, T., Azar, A., Altinok, O., Orynbayeva, Z., & Sell, C. (2018) · GeroScience · doi:10.1007/s11357-018-0030-2 · Cited by 58
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
Chakrabarty, A., Chakraborty, S., Bhattacharya, R., & Chowdhury, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674354 · Cited by 62
Ma, K., Xu, Q., Wang, S., Zhang, W., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.045 · Cited by 62
Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease
Chernova, T. A., Sun, X. M., Powley, I. R., Galavotti, S., Grosso, S., Murphy, F. A., Miles, G. J., Cresswell, L., Antonov, A. V., Bennett, J. A., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.165 · Cited by 54
Ravà, M., D’Andrea, A., Nicoli, P., Gritti, I., Donati, G., Doni, M., Giorgio, M., Olivero, D., & Amati, B. B. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8723 · Cited by 54
Luo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 72
“50 Notably, augmented glutamine intake by cancer cells provides a nitrogen source for nucleotide synthesis, aiding in evasion of the TIS state and acquisition of CSC-like properties.”
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L., Simonnet, H., & Bernard, D. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.63 · Cited by 52
Next-Generation in vivo Modeling of Human Cancers
Gargiulo, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00429 · Cited by 59
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 58
“However, even when ROS-derived senescence occurs, this may paradoxically result in increased proliferation via cell-extrinsic secretion of mitogenic factors to neighboring cells (88, 89).”
BackgroundInnate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50
IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
Homann, L., Rentschler, M., Brenner, E., Böhm, K., Röcken, M., & Wieder, T. (2022) · Cells · doi:10.3390/cells11091514 · Cited by 66
“Similar to the RNA-based data, the levels of secreted cytokines and chemokines in the supernatants were severalfold higher in the SASP of cytokine-treated SK-MEL-28 and WM115 cells (CIS) as compared to the SASP of the respective therapeutic drug-treated melanoma cells (TIS; Figure 5a,b).”
InfluentialRichards, K. A., Liou, J., Cryns, V. L., Downs, T. M., Abel, E. J., & Jarrard, D. F. (2018) · The Journal of Urology · doi:10.1016/j.juro.2018.06.031 · Cited by 56
Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria
Fan, Y., Cheng, J., Zeng, H., & Shao, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.593630 · Cited by 51
Fan, X., He, Y., Wu, G., Chen, H., Cheng, X., Zhan, Y., An, C., Chen, T., & Wang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119411 · Cited by 58
Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells
Delfarah, A., Parrish, S., Junge, J. A., Yang, J., Seo, F., Li, S., Mac, J., Wang, P., Fraser, S. E., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005806 · Cited by 51
“In both aging (2) and cancer (59), therapeutic targeting of senescence has shown great promise.”
Background
Metadata
- Authors
- Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B., Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U., Buck, A. K., Dörken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Max Delbrück Center (DE)
- German Cancer Research Center (DE)
- Technical University of Munich (DE)
- Johannes Gutenberg University Mainz (DE)
- Jena University Hospital (DE)
- Universitätsklinikum Würzburg (DE)
- Max Planck Institute of Molecular Plant Physiology (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 501
- Issue
- 7467
- Pages
- 421-425
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987142903
- Cited by
- 541
- References
- 46
- Citations by year
- 2026: 24 · 2025: 35 · 2024: 42 · 2023: 42 · 2022: 40 · 2021: 55 · 2020: 57 · 2019: 35 · 2018: 45 · 2017: 37 · 2016: 43 · 2015: 41 · 2014: 44 · 2013: 1
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, therapy-induced senescence, synthetic lethality, metabolic targeting, glucose metabolism, autophagy inhibition, senescence-associated secretory phenotype, proteotoxic stress, endoplasmic reticulum stress, unfolded protein response, SUV39H1, H3K9 methylation, Eμ-Myc lymphoma, chemotherapy-induced senescence
- MeSH terms
- Animals, Autophagy, Disease Models, Animal, Female, Glucose, Male, Mice, Transgenic, Stress, Physiological, Survival Rate, Lymphoma, B-Cell, Cellular Senescence, Apoptosis, Mice, Caspase 3, Caspase 12, Proteolysis, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.